Trial intelligence / Profile preview

Dexmedetomidine-supplemented PCIA after orthopedic surgery in elderly patients

ChiCTR1800017182Phase 4Completed

Sponsor
Peking University First Hospital
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine group with Placebo group (2 arms). Primary endpoint: Incidence of delirium within the first 5 days after surgery. Started Oct 2018; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR1800017182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800017182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call